Literature DB >> 16222660

New approach for the refinement of the location of the X-chromosome breakpoint in a previously described female patient with choroideremia carrying a X;4 translocation.

M García-Hoyos1, R Sanz, D Diego-Alvarez, I Lorda-Sánchez, M J Trujillo-Tiebas, D Cantalapiedra, C Ramos, C Ayuso.   

Abstract

Choroideremia (CHM) is an X-linked recessive ophthalmic disease characterized by a progressive degeneration of the choroid and the pigmented epithelium of the retina. We present the genetic characterization of a female patient affected with CHM who has been previously studied cytogenetically and showed a balanced translocation between chromosomes X and 4 [46,X,t(X;4)(q21;p16)]. The breakpoint in the X chromosome lies in the locus of CHM gene and for this reason, we have elucidated whether or not CHM was disrupted in the X chromosome involved in the translocation using different techniques. FISH showed that the 3'UTR and the last exons of the CHM were on the der(X) chromosome, and the 5'UTR and first exons of this gene were on the der(4) chromosome. Expression level analysis revealed that the breakpoint in the der(X) was located between exons 8 and 9 of the CHM gene because the expression level decreased from this point onwards. Based on this result the expression level analysis proved to be a valid method to pinpoint the location of breakpoints when the gene being expressed in peripheral blood is disrupted. Our results confirmed that the CHM gene was indeed disrupted in the X chromosome involved in the translocation. Besides, the nonrandom inactivation of the normal X chromosome observed using a methylation-specific polymerase chain reaction (M-PCR) technique explained the CHM in the female patient. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16222660     DOI: 10.1002/ajmg.a.30987

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia.

Authors:  Nejla Erkilic; Vincent Gatinois; Simona Torriano; Pauline Bouret; Carla Sanjurjo-Soriano; Valerie De Luca; Krishna Damodar; Nicolas Cereso; Jacques Puechberty; Rocio Sanchez-Alcudia; Christian P Hamel; Carmen Ayuso; Isabelle Meunier; Franck Pellestor; Vasiliki Kalatzis
Journal:  Cells       Date:  2019-09-11       Impact factor: 6.600

Review 2.  Systematic review of differential methylation in rare ophthalmic diseases.

Authors:  Katie Kerr; Helen McAneney; Laura Smyth; Cheryl Flanagan; Julie Silvestri; Micheal Andrew Nesbitt; Christopher Wooster; Amy Jayne McKnight
Journal:  BMJ Open Ophthalmol       Date:  2019-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.